Xiaoping Yang

8.3k total citations · 1 hit paper
208 papers, 6.5k citations indexed

About

Xiaoping Yang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Xiaoping Yang has authored 208 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Molecular Biology, 38 papers in Cardiology and Cardiovascular Medicine and 29 papers in Oncology. Recurrent topics in Xiaoping Yang's work include Metabolism, Diabetes, and Cancer (17 papers), Nitric Oxide and Endothelin Effects (16 papers) and Neuropeptides and Animal Physiology (15 papers). Xiaoping Yang is often cited by papers focused on Metabolism, Diabetes, and Cancer (17 papers), Nitric Oxide and Endothelin Effects (16 papers) and Neuropeptides and Animal Physiology (15 papers). Xiaoping Yang collaborates with scholars based in China, United States and Japan. Xiaoping Yang's co-authors include Jun Ren, Mei Peng, Sreejayan Nair, Shigetoshi Chiba, George T. Tsao, Mary E. Rayborn, K.G. Shadrach, Vera L. Bonilha, Joe G. Hollyfield and Lu Liang and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Medicine.

In The Last Decade

Xiaoping Yang

203 papers receiving 6.4k citations

Hit Papers

Oxidative damage–induced inflammation initiates age-relat... 2008 2026 2014 2020 2008 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoping Yang China 45 2.9k 1.3k 829 694 682 208 6.5k
Peter Kružliak Czechia 39 1.7k 0.6× 749 0.6× 438 0.5× 386 0.6× 387 0.6× 221 5.0k
Nanping Wang China 50 3.9k 1.3× 817 0.7× 1.2k 1.4× 845 1.2× 1.0k 1.5× 167 7.7k
Gianfranco Pintus Italy 46 2.8k 0.9× 602 0.5× 886 1.1× 688 1.0× 614 0.9× 159 7.2k
Suresh C. Tyagi United States 52 2.7k 0.9× 1.3k 1.0× 947 1.1× 425 0.6× 309 0.5× 192 8.2k
Lina Wang China 45 3.4k 1.2× 787 0.6× 1.1k 1.3× 705 1.0× 1.1k 1.6× 273 7.1k
Yi Tan China 54 4.7k 1.6× 1.3k 1.1× 968 1.2× 492 0.7× 591 0.9× 190 8.8k
Agapios Sachinidis Germany 47 4.2k 1.4× 955 0.8× 697 0.8× 610 0.9× 626 0.9× 275 7.5k
Fan Jiang China 42 2.4k 0.8× 561 0.4× 630 0.8× 246 0.4× 1.1k 1.7× 173 5.9k
Jun‐ichi Abe United States 58 5.6k 1.9× 2.0k 1.6× 833 1.0× 978 1.4× 1.6k 2.3× 236 10.5k
Savita Khanna United States 56 4.5k 1.5× 618 0.5× 1.9k 2.2× 379 0.5× 734 1.1× 150 11.1k

Countries citing papers authored by Xiaoping Yang

Since Specialization
Citations

This map shows the geographic impact of Xiaoping Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Yang more than expected).

Fields of papers citing papers by Xiaoping Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Yang. The network helps show where Xiaoping Yang may publish in the future.

Co-authorship network of co-authors of Xiaoping Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoping Yang. A scholar is included among the top collaborators of Xiaoping Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoping Yang. Xiaoping Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Weimin, et al.. (2025). Inhibition of Cyclin D1 by Novel Biguanide Derivative YB-004 Increases the Sensitivity of Bladder Cancer to Olaparib via Causing G0 / G1 Arrest. International Journal of Biological Sciences. 21(5). 1984–1998. 2 indexed citations
2.
Ding, Ning, Bahijja Tolulope Raimi‐Abraham, Steven Lynham, et al.. (2025). Mechanistic insight into human milk extracellular vesicle‐intestinal barrier interactions. Journal of Extracellular Biology. 4(1). e70032–e70032. 2 indexed citations
3.
Li, Duo, et al.. (2024). Progress in antitumor mechanisms and applications of phenformin (Review). Oncology Reports. 52(5). 1 indexed citations
4.
Yang, Xiaoping, et al.. (2023). POS0288 DEGRANULATING PR3+ MYELOID CELLS CHARACTERIZE PROLIFERATIVE LUPUS NEPHRITIS. Annals of the Rheumatic Diseases. 82. 385–386.
5.
Yang, Xiaoping, et al.. (2023). Ficolin A knockout alleviates sepsis-induced severe lung injury in mice by restoring gut Akkermansia to inhibit S100A4/STAT3 pathway. International Immunopharmacology. 121. 110548–110548. 8 indexed citations
6.
Zheng, Xiaoyi, Lauren E. Higdon, Alexandre Gaudet, et al.. (2022). Endothelial Cell-Specific Molecule-1 Inhibits Albuminuria in Diabetic Mice. Kidney360. 3(12). 2059–2076. 1 indexed citations
7.
Peng, Mei, et al.. (2022). Protective effects of metformin in various cardiovascular diseases: Clinical evidence and AMPK‐dependent mechanisms. Journal of Cellular and Molecular Medicine. 26(19). 4886–4903. 66 indexed citations
8.
Cheng, Yao, et al.. (2022). CircLPAR3 knockdown suppresses esophageal squamous cell carcinoma cell oncogenic phenotypes and Warburg effect through miR-873-5p/LDHA axis. Human & Experimental Toxicology. 41. 3520161935–3520161935. 4 indexed citations
9.
Daneshpajouhnejad, Parnaz, Xiaoping Yang, Xiaoxin X. Wang, et al.. (2022). PodoCount: A Robust, Fully Automated, Whole-Slide Podocyte Quantification Tool. Kidney International Reports. 7(6). 1377–1392. 8 indexed citations
10.
Wang, Kaiyang, et al.. (2022). Prevalence and Risk Factors of Abnormal Carotid Artery in Young Adults without Overt Cardiovascular Disease. International Journal of General Medicine. Volume 15. 4595–4601. 4 indexed citations
11.
Liu, Huan, Yingying Chen, Cheng Yan, et al.. (2020). Immunosensing of NT‐proBNP via Cu2+‐based MOFs Biolabeling and in situ Microliter‐droplet Anodic Stripping Voltammetry. Electroanalysis. 32(8). 1754–1762. 8 indexed citations
12.
Yi, Haiqing, Yan Cheng, Yu Zhang, Qingji Xie, & Xiaoping Yang. (2020). Potentiometric and UV-Vis spectrophotometric titrations for evaluation of the antioxidant capacity of chicoric acid. RSC Advances. 10(20). 11876–11882. 5 indexed citations
13.
Peng, Mei, Jun Deng, Sichun Zhou, et al.. (2019). Dual Inhibition of Pirarubicin-Induced AKT and ERK Activations by Phenformin Sensitively Suppresses Bladder Cancer Growth. Frontiers in Pharmacology. 10. 1159–1159. 19 indexed citations
14.
Zhu, Li, et al.. (2018). Construction of a nursing quality indicator system for perioperative patients with degenerative cervical spondylopathy. Zhonghua xiandai huli zazhi. 24(21). 2507–2511. 1 indexed citations
15.
Gui, Jun, Michael D. Gober, Xiaoping Yang, et al.. (2016). Therapeutic Elimination of the Type 1 Interferon Receptor for Treating Psoriatic Skin Inflammation. Journal of Investigative Dermatology. 136(10). 1990–2002. 28 indexed citations
16.
Yang, Xiaoping, et al.. (2015). Cerebrospinal Fluid Free Fatty Acid Levels Are Associated with Stroke Subtypes and Severity in Chinese Patients with Acute Ischemic Stroke. World Neurosurgery. 84(5). 1299–1304. 13 indexed citations
17.
Wang, Shuiliang, Jingcao Huang, Hui Lyu, et al.. (2013). Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer. Breast Cancer Research. 15(5). R101–R101. 42 indexed citations
18.
Yang, Xiaoping, Xianzhong Meng, Xin Su, et al.. (2009). Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: Role of Smad1 and extracellular signal-regulated kinase 1/2. Journal of Thoracic and Cardiovascular Surgery. 138(4). 1008–1015.e1. 103 indexed citations
19.
Nair, Sreejayan, et al.. (2008). Antioxidant properties of argpyrimidine. European Journal of Pharmacology. 593(1-3). 30–35. 16 indexed citations
20.
Yang, Xiaoping & Shigetoshi Chiba. (2000). Dissociation of Potentiation of Leu31 Pro34 Neuropeptide Y on Adrenergic and Purinergic Transmission in Isolated Canine Splenic Artery. The Japanese Journal of Pharmacology. 83(3). 197–205. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026